| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adjuvant chemotherapy following stereotactic body radiotherapy for early stage non-small-cell lung cancer is associated with lower overall: A National Cancer Database Analysis
|
Foster, Corey C.
|
|
2019
|
130 |
C |
p. 162-168
|
artikel
|
| 2 |
Antibiotics are associated with attenuated efficacy of anti-PD-1/PD-L1 therapies in Chinese patients with advanced non-small cell lung cancer
|
Zhao, Sha
|
|
2019
|
130 |
C |
p. 10-17
|
artikel
|
| 3 |
A study of ALK-positive pulmonary squamous-cell carcinoma: From diagnostic methodologies to clinical efficacy
|
Wang, Haiyue
|
|
2019
|
130 |
C |
p. 135-142
|
artikel
|
| 4 |
Capitalizing on a teachable moment: Development of a targeted self-help smoking cessation intervention for patients receiving lung cancer screening
|
Meltzer, Lauren R.
|
|
2019
|
130 |
C |
p. 121-127
|
artikel
|
| 5 |
Clinical value of neutrophil-to-lymphocyte ratio in patients with non-small-cell lung cancer treated with PD-1/PD-L1 inhibitors
|
Jiang, Tao
|
|
2019
|
130 |
C |
p. 76-83
|
artikel
|
| 6 |
CNS metastasis in ROS1+ NSCLC: An urgent call to action, to understand, and to overcome
|
Ou, Sai-Hong Ignatius
|
|
2019
|
130 |
C |
p. 201-207
|
artikel
|
| 7 |
Contents
|
|
|
2019
|
130 |
C |
p. v-vii
|
artikel
|
| 8 |
Correlation study between dual source CT perfusion imaging and the microvascular composition of solitary pulmonary nodules
|
Wang, Meng
|
|
2019
|
130 |
C |
p. 115-120
|
artikel
|
| 9 |
Corrigendum to “Genetic alterations of driver genes as independent prognostic factors for disease-free survival in patients with resected non-small cell lung cancer” [Lung Cancer 128 (2019) 152–157]
|
Ono, Akira
|
|
2019
|
130 |
C |
p. 226
|
artikel
|
| 10 |
Cost-effectiveness analysis of atezolizumab plus chemotherapy in the first-line treatment of extensive-stage small-cell lung cancer
|
Zhou, Kexun
|
|
2019
|
130 |
C |
p. 1-4
|
artikel
|
| 11 |
Editorial Board/Aims and Scope
|
|
|
2019
|
130 |
C |
p. iii
|
artikel
|
| 12 |
Efficacy and long-term survival of advanced lung adenocarcinoma patients with uncommon EGFR mutations treated with 1st generation EGFR-TKIs compared with chemotherapy as first-line therapy
|
Li, Haixia
|
|
2019
|
130 |
C |
p. 42-49
|
artikel
|
| 13 |
Erlotinib versus gemcitabine/cisplatin in Chinese patients with EGFR mutation-positive advanced non-small-cell lung cancer: Crossover extension and post-hoc analysis of the ENSURE study
|
Wu, Yi-Long
|
|
2019
|
130 |
C |
p. 18-24
|
artikel
|
| 14 |
High BIN1 expression has a favorable prognosis in malignant pleural mesothelioma and is associated with tumor infiltrating lymphocytes
|
Ahmadzada, Tamkin
|
|
2019
|
130 |
C |
p. 35-41
|
artikel
|
| 15 |
Highly expressed EZH2 in combination with BAP1 and MTAP loss, as detected by immunohistochemistry, is useful for differentiating malignant pleural mesothelioma from reactive mesothelial hyperplasia
|
Yoshimura, Masayo
|
|
2019
|
130 |
C |
p. 187-193
|
artikel
|
| 16 |
IKKβ targeting reduces KRAS-induced lung cancer angiogenesis in vitro and in vivo: A potential anti-angiogenic therapeutic target
|
Carneiro-Lobo, Tatiana Correa
|
|
2019
|
130 |
C |
p. 169-178
|
artikel
|
| 17 |
Imaging in pleural mesothelioma: A review of the 14th International Conference of the International Mesothelioma Interest Group
|
Armato III, Samuel G.
|
|
2019
|
130 |
C |
p. 108-114
|
artikel
|
| 18 |
Lung cancer mortality in Australia in the twenty-first century: How many lives can be saved with effective tobacco control?
|
Luo, Qingwei
|
|
2019
|
130 |
C |
p. 208-215
|
artikel
|
| 19 |
MET Y1003S point mutation shows sensitivity to crizotinib in a patient with lung adenocarcinoma
|
Miao, Yun L.
|
|
2019
|
130 |
C |
p. 84-86
|
artikel
|
| 20 |
Mutation patterns in a population-based non-small cell lung cancer cohort and prognostic impact of concomitant mutations in KRAS and TP53 or STK11
|
La Fleur, Linnéa
|
|
2019
|
130 |
C |
p. 50-58
|
artikel
|
| 21 |
Nivolumab-refractory patients with advanced non-small-cell lung cancer
|
Costantini, A.
|
|
2019
|
130 |
C |
p. 128-134
|
artikel
|
| 22 |
Pathologic nodal clearance and complete response following neoadjuvant chemoradiation for clinical N2 non-small cell lung cancer: Predictors and long-term outcomes
|
Haque, Waqar
|
|
2019
|
130 |
C |
p. 93-100
|
artikel
|
| 23 |
Patient reported outcome data as performance indicators in surgically treated lung cancer patients
|
Brønserud, Majken M.
|
|
2019
|
130 |
C |
p. 143-148
|
artikel
|
| 24 |
Patterns of progression on osimertinib in EGFR T790M positive NSCLC: A Swiss cohort study
|
Schmid, S.
|
|
2019
|
130 |
C |
p. 149-155
|
artikel
|
| 25 |
Pembrolizumab in combination with ipilimumab as second-line or later therapy for advanced non–small-cell lung cancer: KEYNOTE-021 cohorts D and H
|
Gubens, Matthew A.
|
|
2019
|
130 |
C |
p. 59-66
|
artikel
|
| 26 |
Pharmacokinetically-guided dosing of pemetrexed in a patient with renal impairment and a patient requiring hemodialysis
|
de Rouw, N.
|
|
2019
|
130 |
C |
p. 156-158
|
artikel
|
| 27 |
Potential for the blood-based biomarkers cytokeratin 19 fragment (CYFRA 21-1) and human epididymal protein 4 (HE4) to detect recurrence during monitoring after surgical resection of adenocarcinoma of the lung
|
Muley, Thomas
|
|
2019
|
130 |
C |
p. 194-200
|
artikel
|
| 28 |
Prevalence and prognostic value of PD-L1 expression in molecular subtypes of metastatic large cell neuroendocrine carcinoma (LCNEC)
|
Hermans, B.C.M.
|
|
2019
|
130 |
C |
p. 179-186
|
artikel
|
| 29 |
PTEN inactivation induces epithelial-mesenchymal transition and metastasis by intranuclear translocation of β-catenin and snail/slug in non-small cell lung carcinoma cells
|
Perumal, Elumalai
|
|
2019
|
130 |
C |
p. 25-34
|
artikel
|
| 30 |
Radical consolidative treatment provides a clinical benefit and long-term survival in patients with synchronous oligometastatic non-small cell lung cancer: A phase II study
|
Arrieta, Oscar
|
|
2019
|
130 |
C |
p. 67-75
|
artikel
|
| 31 |
Repeat biopsy procedures and T790M rates after afatinib, gefitinib, or erlotinib therapy in patients with lung cancer
|
Lee, Kangkook
|
|
2019
|
130 |
C |
p. 87-92
|
artikel
|
| 32 |
Safety and efficacy of PD-1 inhibitors in non–small cell lung cancer patients positive for antinuclear antibodies
|
Yoneshima, Yasuto
|
|
2019
|
130 |
C |
p. 5-9
|
artikel
|
| 33 |
The association between tumor burden and severe immune-related adverse events in non-small cell lung cancer patients responding to immune-checkpoint inhibitor treatment
|
Sakata, Yoshihiko
|
|
2019
|
130 |
C |
p. 159-161
|
artikel
|
| 34 |
The distress thermometer as a prognostic tool for one-year survival among patients with lung cancer
|
Geerse, O.P.
|
|
2019
|
130 |
C |
p. 101-107
|
artikel
|
| 35 |
Treatment and outcome of 432 patients with extensive-stage small cell lung cancer in first, second and third line – Results from the prospective German TLK cohort study
|
Steffens, Claus-Christoph
|
|
2019
|
130 |
C |
p. 216-225
|
artikel
|
Tijdschrift beschrijving